ELXR
Dead / Abandoned — Abandoned — failure to respond (as of 07 Aug 2023)
What this means for you
This application is over — abandoned 21 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97761836
- Mark type
- Stylized text
- Filed
- 20 Jan 2023
- Abandoned
- 21 Jun 2023
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 042 — Scientific and technological services: Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, diagnostic and therapeutic products and services; Design and development of engineered cells for use in scientific research and drug discovery and development; Providing medical research and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering
Owner
- Scribe Therapeutics Inc., Alameda, CA, US
Prosecution history
- 07 Aug 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 07 Aug 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 07 Aug 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 20 Mar 2023 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 20 Mar 2023 — PRIORITY ACTION E-MAILED
- 20 Mar 2023 — PRIORITY ACTION WRITTEN
- 09 Mar 2023 — ASSIGNED TO EXAMINER
- 09 Feb 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Jan 2023 — NEW APPLICATION ENTERED